Filed: 5/8/2026ACC: 0001123292-26-000642
📋 What this filing means
GILEAD SCIENCES, INC. filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $2.12B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$2.12B
Total AUM (reported)
64.13M
Total Shares
Allocation by class
COM$1.49B70.4%
SPON ADR$501.22M23.7%
COM NEW$125.02M5.9%
Portfolio Concentration
Top 3$1.95B92.2%
4–10$166.10M7.8%
Top 3 weight
92.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 64.13M
Sole
Full voting authority
64.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other1
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Arcellx Inc
SOLEShares6.72M
TypeSH
Market value$771.68M
36.44%
Sole
6.72M
Shared
0.00
None
0.00
Arcus Biosciences Inc
SOLEShares31.42M
TypeSH
Market value$678.77M
32.05%
Sole
31.42M
Shared
0.00
None
0.00
Galapagos NV
DFNDShares16.71M
TypeSH
Market value$501.22M
23.67%
Sole
16.71M
Shared
0.00
None
0.00
Assembly Biosciences Inc
SOLEShares4.51M
TypeSH
Market value$125.02M
5.90%
Sole
4.51M
Shared
0.00
None
0.00
Kyverna Therapeutics Inc
SOLEShares4.13M
TypeSH
Market value$35.61M
1.68%
Sole
4.13M
Shared
0.00
None
0.00
Xilio Therapeutics Inc
SOLEShares650.39K
TypeSH
Market value$5.47M
0.26%
Sole
650.39K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Arcellx IncSOLE | COM | 6.72M | SH | $771.68M 36.44% | 6.72M | 0.00 | 0.00 |
Arcus Biosciences IncSOLE | COM | 31.42M | SH | $678.77M 32.05% | 31.42M | 0.00 | 0.00 |
Galapagos NVDFND | SPON ADR | 16.71M | SH | $501.22M 23.67% | 16.71M | 0.00 | 0.00 |
Assembly Biosciences IncSOLE | COM NEW | 4.51M | SH | $125.02M 5.90% | 4.51M | 0.00 | 0.00 |
Kyverna Therapeutics IncSOLE | COM | 4.13M | SH | $35.61M 1.68% | 4.13M | 0.00 | 0.00 |
Xilio Therapeutics IncSOLE | COM | 650.39K | SH | $5.47M 0.26% | 650.39K | 0.00 | 0.00 |